Sarepta Surges 74% On Plans For Drug Application
April 21, 2014 at 07:40 AM EDT
Shares of Sarepta Therapeutics Inc. surged 74% premarket after the company said it plans to submit a new drug application for the treatment of Duchenne muscular dystrophy to the U.S. Food and Drug Administration by year end.
